Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Schenk EL, Patil T, Pacheco J, Bunn PA. 2020 Innovation-based optimism for Lung Cancer outcomes. Oncologist. 2021;26:e454–72.

Article  PubMed  Google Scholar 

Wang K, Tepper JE. Radiation therapy-associated toxicity: etiology, management, and prevention. CA Cancer J Clin. 2021;71:437–54.

Article  PubMed  Google Scholar 

Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 2000;48:1015–24.

Article  CAS  PubMed  Google Scholar 

Liu W, Shao Y, Guan B, Hao J, Cheng X, Ji K, et al. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection. Int J Clin Exp Pathol. 2015;8:11268–77.

PubMed  PubMed Central  Google Scholar 

Luchini C, Veronese N, Nottegar A, Cheng M, Kaneko T, Pilati C, et al. Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis. Virchows Arch. 2018;472:939–47.

Article  PubMed  Google Scholar 

Lee YC, Wu CT, Kuo SW, Tseng YT, Chang YL. Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer. Chest. 2007;131:993–9.

Article  PubMed  Google Scholar 

Xie H, Dai C, Gu C, Zhao S, Xu L, Wang F, et al. Validation of the Proposed International Association for the study of Lung Cancer residual tumor classification to Upgrade Extracapsular Extension of Tumor in Nodes from R0 to Incomplete Resection. J Thorac Oncol. 2024;19:130–40.

Article  PubMed  Google Scholar 

Yuan S, Meng X, Yu J, Mu D, Chao KS, Zhang J, et al. Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;67:727–34.

Article  PubMed  Google Scholar 

Rosell R, Gómez-Codina J, Camps C, Maestre J, Padille J, Cantó A, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153–8.

Article  CAS  PubMed  Google Scholar 

Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr., Lee JS, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst. 1994;86:673–80.

Article  CAS  PubMed  Google Scholar 

Pisters KM, Vallières E, Crowley JJ, Franklin WA, Bunn PA Jr., Ginsberg RJ, et al. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol. 2010;28:1843–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Felip E, Rosell R, Maestre JA, Rodríguez-Paniagua JM, Morán T, Astudillo J, et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. J Clin Oncol. 2010;28:3138–45.

Article  CAS  PubMed  Google Scholar 

Scagliotti GV, Pastorino U, Vansteenkiste JF, Spaggiari L, Facciolo F, Orlowski TM, et al. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer. J Clin Oncol. 2012;30:172–8.

Article  CAS  PubMed  Google Scholar 

Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, et al. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. N Engl J Med. 2022;386:1973–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, et al. Perioperative Pembrolizumab for Early-Stage Non-small-cell Lung Cancer. N Engl J Med. 2023;389:491–503.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cascone T, Awad MM, Spicer J, He J, Lu S, Sepesi B et al. LBA1 CheckMate 77T: phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC. Annals of Oncology. 2023.

Dillman RO, Herndon J, Seagren SL, Eaton WL Jr., Green MR. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst. 1996;88:1210–5.

Article  CAS  PubMed  Google Scholar 

Sause W, Kolesar P, Taylor SI, Johnson D, Livingston R, Komaki R et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest. 2000; 117:358–364.

Guo X, Zhou Y, Ji Y, Lou W, Wu L, Wang W. TisCRT-LAPC: a phase II study of tislelizumab combined with nab-paclitaxel and gemcitabine (AG) followed by consolidative radiotherapy in locally advanced pancreatic cancer (LAPC). J Clin Oncol. 2024;42:e16350–16350.

Article  Google Scholar 

Chen D, Zou B, Li B, Gao A, Huang W, Shao Q, et al. Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC): a phase II trial. EClinicalMedicine. 2024;75:102795.

Article  PubMed  PubMed Central  Google Scholar 

Reck M, Nadal E, Girard N, Filippi AR, Martin LW, Gay CM, et al. MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy followed by either surgery and adjuvant durvalumab or chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable stage IIB-IIIB NSCLC. Clin Lung Cancer. 2024;25:587–e593583.

Article  CAS  PubMed  Google Scholar 

Apisarnthanarax S, Elliott DD, El-Naggar AK, Asper JA, Blanco A, Ang KK, et al. Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys. 2006;64:678–83.

Article  PubMed  Google Scholar 

Wang ZW, Zhang W, Dong W, Li BS, Mu DB, Huang W, et al. Pathological analysis of extracapsular extension of metastatic lymph node and its potential impact on nodal clinical target volume in the radiotherapy of esophageal squamous cell carcinoma. Neoplasma. 2014;61:324–30.

Article  CAS  PubMed  Google Scholar 

Nie S, Zhu Y, Yang J, Xin T, Xue S, Sun J, et al. Clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning. BMC Med. 2021;19:269.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu X, Bao Y, Xu YJ, Zhu HN, Liu JS, Zhang L, et al. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses. Cancer. 2020;126:840–9.

Article  CAS  PubMed  Google Scholar 

Meynard C, Mansuet-Lupo A, Giraud N, Boulle G, Imbault P, Guénégou-Arnoux A, et al. Size and predictive factors of microscopic tumor extension in locally Advanced Non-small Cell Lung Cancer. Pract Radiat Oncol. 2021;11:491–501.

Article  PubMed  Google Scholar 

Ghadjar P, Schreiber-Facklam H, Gräter R, Evers C, Simcock M, Geretschläger A, et al. Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2010;76:1127–32.

Article  PubMed  Google Scholar 

Schmitt M, Aussenac L, Seitlinger J, Lindner V, Noël G, Antoni D. Evaluation of microscopic Tumour Extension in Localized Stage Non-small-cell Lung Cancer for Stereotactic Radiotherapy Planning. Cancers (Basel). 2022;14:1282.

Li WL, Yu JM, Liu GH, Zhong WX, Li WW, Zhang BJ. [A comparative study on radiology and pathology target volume in non-small-cell lung cancer]. Zhonghua Zhong Liu Za Zhi. 2003;25:566–8.

PubMed  Google Scholar 

Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979–90.

Article  CAS  PubMed  Google Scholar 

Hoffman MS, Gunesakaran S, Arango H, DeCesare S, Fiorica JV, Parsons M, et al. Lateral microscopic extension of squamous cell carcinoma of the vulva. Gynecol Oncol. 1999;73:72–5.

Article  CAS  PubMed  Google Scholar 

Gao L, Wang X, Yang X, Gu R, Zhu G, Gao X. A clinicopathologic analysis of microscopic extension in small cell lung cancer and lung adenocarcinoma: determination of clinical target volume with precise radiotherapy. Thorac Cancer. 2021;12:1973–82.

Article  PubMed  PubMed Central